1. Ergebnisse der perkutanen Strahlentherapie des lokalisierten Prostatakarzinoms
- Author
-
Scherer E, Mellin P, Schmitt G, Lenz W, and Schulte-Vels K
- Subjects
Oncology ,medicine.medical_specialty ,Percutaneous ,business.industry ,medicine.medical_treatment ,General Medicine ,medicine.disease ,Radiation therapy ,medicine.anatomical_structure ,Prostate ,Internal medicine ,medicine ,Carcinoma ,Radiology ,Stage (cooking) ,business ,Survival rate - Abstract
Analysing preliminary results of percutaneous radiotherapy on 79 patients with localized prostatic carcinoma, the uncorrected five-year survival rate of all patients was 67.3%, that in stage O, A and B 89.5% and that of patients in stage C and D 64.5%. The tumour-free five-year survival rate of all patients was 50.2%. In three patients there was a recurrence (4%), in four others severe side-effects (5%). There were no fatal complications. Radiotherapy can be considered to be an alternative to operation even when the tumour is limited to the prostate.
- Published
- 2008
- Full Text
- View/download PDF